1. Stats
  2. USPTO
  3. TC 1600
  4. Group 1610
  5. Art Unit 1619
  6. Examiner Kassa

Examiner Kassa Tigabu

1619-KASSA-TIGABU

Employment Information

Art Unit:1619 — Drug, bio-affecting and body treating compositions
Group:1610 — Pharmaceutical and Agricultural Compositions; Plant Growth Regulating Compositions: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs; In vivo Diagnostic Agents
Classes: 424 — Drug, bio-affecting and body treating compositions
514 — Drug, bio-affecting and body treating compositions
132 — Toilet
504 — Plant protecting and regulating compositions
530 — Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
433 — Dentistry
264 — Plastic and nonmetallic article shaping or treating: processes
Phone:(571) 270-5867
Email:tigabu.kassa@uspto.gov
Location:VA 22314
Title:Pat Examnr Gen Chem
Service:18 years
Grade:GS-14

Grant Rate and Difficulty Ranking

92
3-Year Grant rate: 26% over 227 cases
Difficulty: Extremely Hard
Difficulty Percentile: 92nd

With Examiner Kassa, you have a 26% chance of getting an issued patent by 3 years after the first office action. Examiner Kassa is an extremely hard examiner and in the 92nd percentile across all examiners (with 100th percentile most difficult).

Grant Rate

Grant Rate Timeline

Below is the grant rate timeline for Examiner Kassa, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.

Comparison with Art Unit 1619

Examiner Kassa's grant rate is lower than that of Art Unit 1619 and lower than that of the USPTO.

Average Office Actions Per Grant
Examiner Kassa 3.1
Art Unit 1619 2.4

Interview Benefit

Grant Rate without Interview

Examiner Kassa has granted 50 of 178 cases without any applicant-requested interviews for a grant rate of 28%.

Grant Rate with Interview

Examiner Kassa has granted 10 of 49 cases with at least one applicant-requested interview for a grant rate of 20%.

Interview Benefit

With Examiner Kassa, conducting an interview decreases your chance of getting a patent granted by 29%.

Recent Dispositions

Recent Dispositions

Number Title OA Rejections Status IFW
19169843 Use Of Varenicline For Treating Ocular Conditions Rejection information available with a Premium Stats subscription. See our pricing. Patented View
18098473 Biodegradable, Antioxidant, Thermally Responsive Injectable Hydrogel And Uses Therefor Patented View
16637219 Apoptosis-Mimicking Structures For Inducing Tissue Regeneration Patented View
17960002 Ultrafine Nanoparticles Comprising A Functionalized Polyorganosiloxane Matrix And Including Metal Complexes; Method For Obtaining Same And Uses Thereof In Medical Imaging And/or Therapy Patented View
18255673 Compressed Tablets Comprising Hmo Abandoned View
17157047 Stable Multiparticulate Pharmaceutical Composition Of Rosuvastatin Patented View
18541995 Long-Term Stable Live Fecal Microbiota Composition Patented View
17649464 Methods And Compositions For Inhibiting Glyoxalase 1 (Glo1) Patented View
16218051 Elastomeric Nanocomposite Hydrogels Patented View
18541570 Intraocular Pressure Reduction With Intracameral Bimatoprost Implants Abandoned View
17648380 Preparation Method Of Sustained-Release Microparticles Abandoned View
17044599 Granulation Composition Formed From Core Particles, Coating Particles And A Binder Patented View
18170634 Antiviral Resilient Flooring Abandoned View
18019582 Solid Dosage Forms Of Palbociclib Abandoned View
17895681 Method Of Preparing A Thin Film Composite Layer Abandoned View
18370106 Interpenetrating Polymer Network Hydrogel Abandoned View
17945328 Methods Of Using Activin Receptor Type Iib Variants Patented View
17798285 Cd137 Binding Molecules And Uses Thereof Patented View
18895498 Pharmaceutical Compositions Of Cabotegravir Abandoned View
17801440 Solid Preparation Abandoned View
17796365 Diclofenac Sodium-Containing Adhesive Patch Abandoned View
16704699 Compositions And Methods For Treating Acute Cannabinoid Overdose With A Cannabinoid Receptor Antagonist Abandoned View
16646336 Method For Preparing A Solid Dosage Form Comprising Antibodies By Wet Granulation, Extrusion And Spheronization Patented View
16489609 Zwitterionic Dendritic Amphiphiles, Zwitterionic Dendrimers, Zwitterionic Telodendrimers, Nanocarriers Comprising Same, And Methods Of Making And Using Same Patented View
16522739 Personal Cleansing Compositions, Methods And Uses Patented View
16604078 Cold-Water-Dispersible Chemical Delivery System Patented View
18423908 Dry Eye Treatments Abandoned View
18095488 Injectable Preformed Macroscopic 3-Dimensional Scaffolds For Minimally Invasive Administration Abandoned View
17685732 Depilatory Compositions Comprising Aminoalkylpropanol Patented View
17253517 Enzymes Entrapped In Organopolysiloxane Matrix For Treating Intestinal Diseases Patented View
18355618 Modified Release Formulation Abandoned View
17539148 Powder System For The Care Of Hair Abandoned View
17155128 Composition For Washing And Conditioning The Hair Patented View
17539188 Cosmetic Cleansing Powder Abandoned View
17583964 Topical Antiseptic System Patented View
16555669 Pharmaceutical Formulation And System And Method For Delivery Patented View
17591333 Diclofenac Sachet Composition Abandoned View
16391430 Film Dosage Forms Containing Amorphous Active Agents Abandoned View
17942389 Heavy Metal-Free Calcium Hydroxide-Based Active Substance Abandoned View
16983232 Sheet For Covering Wound, And Method For Covering Wound Abandoned View
18236278 Composition For Preventing Adhesion Of Air-Borne Fine Particles Abandoned View
18503232 Combination And Uses And Treatments Thereof Abandoned View
17609525 New Formulations Of Microorganisms Abandoned View
16733360 Compositions And Reagents For Ion Beam Imaging Abandoned View
17498027 Process Of Reworking A Crystalline Form Of A Glycine Transport Inhibitor Patented View
18307378 Erodible Anhydrous Polyethylene Oxide Film Abandoned View
17824420 Tissue Matrices With Controlled Porosity Or Mechanical Properties Abandoned View
17748566 Telodendrimers With Riboflavin Moieties And Nanocarriers And Methods Of Making And Using Same Abandoned View
17261863 Polyhydroxyl-Containing Polymer, Preparation Method Therefor And Use Thereof Abandoned View
17561885 Dual-Rate Release Formulation With High Drug Loading Abandoned View

Appeals Statistics

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access for your law firm.

Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.